Top Markets
Coin of the day
Diagnocure, Inc. Diagnocure, Inc.

Diagnocure, Inc.

DGCRF
Rank in Stocks #41418
Diagnocure, Inc. is a Canadian life sciences company dedicated to developing... Diagnocure, Inc. is a Canadian life sciences company dedicated to developing and commercializing innovative products for cancer diagnosis. Its core business revolves around advanced molecular diagnostic tests designed for the identification and management of cancerous conditions. The company's portfolio includes the PCA3 test for prostate cancer diagnosis, as well as the Guanylyl Cyclase C (GCC) marker and the Previstage GCC colorectal cancer staging test, both vital for patients with colorectal cancer. They also offer PCP, a multi-marker diagnostic for prostate cancer. In addition to these tests, Diagnocure provides specialized services such as gene expression and copy number variation analysis, mutation detection, SNP genotyping, and comprehensive platform and laboratory environmental support. Established in 1994 as 9342-8530 Québec Inc. and previously known as DiagnoCure Inc., the company is headquartered in Quebec, Canada.
Share Price
$0.0001
Last synced: 2025-06-11
Market Cap
$21.52K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
CA
Trade Diagnocure, Inc. (DGCRF)

Category

Stock split history for Diagnocure, Inc. (DGCRF)
Diagnocure, Inc. stock (symbol: DGCRF) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 13, 2026.
One DGCRF share bought prior to Aug 13, 2026 would equal to 0 DGCRF shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors